Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Research and Markets: Next Generation Sequencing (NGS) Report 2013: How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/10/2013 | 04:30pm CET

Research and Markets (http://www.researchandmarkets.com/research/ddm37b/next_generation) has announced the addition of the "Next Generation Sequencing Report 2013" report to their offering.

The Next Generation Sequencing market is poised to reach $4.4B in 2018!

How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

NGS technologies drive the way toward personalized medicine

Our analysis provides 2013-2018 market data, along with player market shares at both equipment and consumable levels. Moreover, positioning strategy of each supplier has been analyzed in the document.

Discover the NGS market's complex organization, splitted in four segments

The market segmentation is a tool used to provide a vision of the market. Based on technical and economic criteria, fours segments have been identified: research, forensics, diagnostics and consumer.

Until recently, uses of Next Generation Sequencing tools were limited to research (human whole genome, exome, small genome, targeted, transcriptome, RNA profiling, chIP-Seq, metagenomics).

Nowadays, NGS technologies have found applications mainly in two fields: clinical diagnostics and forensics.

Our investigation describes both current and future applications.

Next Generation Sequencing technologies overview

  • In April 2003, human genome project was declared complete. This first human genome sequencing took 13 years, mobilized 20000 researchers and cost $3B!
  • Since the early 2000s, sequencing technologies have come a long way from Sanger sequencing (also called 1st generation sequencing) used for the human genome project to the Next Generation Sequencing technologies available today.
  • By sequencing a large number of DNA molecules in parallel after PCR amplification, technology developers have been able to sharply increase machine throughput by a factor of 10, along with a steep price reduction.
  • The launch of a new detection method based on electrochemical detections was also a huge step forward for the sequencing world.
  • Today, based on these new technologies, we can sequence the whole human genome in less than three hours with one laboratory technician and a total cost around $1000.
  • Technologies under development are poised to extend the boundaries with a targeted sequencing cost of $100.
  • All technologies currently in use and those under development are presented in our report. Benchmarking is also presented for eight different sequencing applications.

New opportunities arise for cartridge makers

  • The wide adoption of NGS technology has changed the way NGS suppliers are generating revenue. A shift occurred in the sales mix, moving from instruments to consumables which have a higher gross margin than instruments.
  • This leads to an increase in revenue based on consumable sales.
  • The number of NGS Platforms used worldwide will exploded in the next several years and the run time will continue to decrease. Therefore, the market of NGS consumables will follow.

Report's key features

- 2013-2018 Next Generation Sequencing equipment market

- 2013-2018 Next Generation Sequencing consumable market

- Market segmentation which highlights current and future applications

- Overview of sequencing technologies and cartridges associated

- Detailed supply chain and business model analysis highlighting the major changes expected over next few years

- Company profiles of the main players

Report objectives

- Provide an overview of global NGS market both at equipment and consumable levels.

- Present main players and technologies involved

- Analyze both technical and market trends

- Focus on microfluidic consumable cartridges used for genome testing

- Supply Chain analysis

Key Topics Covered:

1. Executive summary

2. Introduction

3. Market data

4. Market segmentation

5. Next Generation Sequencing technologies overview

6. Value chain and supply chain

7. Market trends and challenges

8. Company profiles

Companies Mentioned

- 23andme

- Affymetrix

- Azco Biotech Inc

- Baseclear

- Base 4

- BGI-Shenzhen

- Completegenomics

- DNAvision

- Genia Technologies

- Genapsys

- GnuBIO

- Hitachi

- Illumina

- LaserGen

- NabSys

- Noblegen Biosciences

- Oxford Nanopore Technologies

- Pacific Biosciences

- Qiagen

- Roche 454

- Stratos Genomics Inc.

- Thermo Fisher Scientific

- TSMC

For more information visit http://www.researchandmarkets.com/research/ddm37b/next_generation

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
12:24p European shares weighed down by insurers, exchange stocks
12:24p STERLITE TECHNOLOGIES : Tech Brings End-to-End Smarter Telecom Solutions to MWC 2017
12:23p Japan Proximity Sensors Market - Growth, Trends And Forecasts with Panasonic Coporation, Fargo Controls and others (2016 - 2021) - Research and Markets
12:22p KELLER : Rotork revenue rises; to benefit from Trump moves on shale, pipelines
12:22p BOMBARDIER : to Provide 21 Additional FLEXITY Trams to Berlin
12:22p UK STATISTICS AUTHORITY : Public confidence in official statistics
12:22p HSBC : Next Day Disclosure Return (Share Buyback) 24 February 2017 - Announcement made to the HK stock exchange - English (3-page PDF 89KB)
12:22p LORENZO INTERNATIONAL : Quarterly Update Pursuant To Rule 1313(2) Of The Listing Manual
12:22p ECHO INVESTMENT : Browary Warszawskie - launch of presales of the 2nd stage
12:22p CALTAGIRONE EDITORE : Purchase of treasury shares 27 february 2017
Latest news
Advertisement
Hot News 
2.55%ESURE : UK insurer esure Group sees 2016 profit ahead of expectations
-7.82%DIRECT LINE INSURANCE : expects lower profit before tax due to discount rate change
-7.69%NOXOPHARM (ASX : NOX) talks applications for its cancer drug candidate NOX66
-3.16%FTSE gains despite insurers, LSE weakness
-3.20%LONDON STOCK EXCHANGE : LSE scuppers Deutsche Boerse merger hopes by rejecting EU demand
Most Read News
04:38a BANK VTB : Russia's VTB plans to slim down in Europe, keep London as hub
05:59a LONDON STOCK EXCHANGE : LSE scuppers Deutsche Boerse merger hopes by rejecting EU demand
05:58a British motor insurance stocks slide as personal injury lump sums to rise
02/26DJOil Prices See Modest Gains; Downside Pressure Remains
12:36a HONG KONG EXCHANGES AND CLEARING : HKEX 2016 profit slides on weak trading volumes, cautious on outlook
Most recommended articles
04:58a Amazon, Netflix grab a share of Oscar glory
02/23DJVIVENDI : Full-Year Earnings Beat Estimates
06:24a European shares weighed down by insurers, exchange stocks
06:22a KELLER : Rotork revenue rises; to benefit from Trump moves on shale, pipelines
06:13aDJGLOBAL LOGISTIC PROPERTIES : U.S. and China Warehousing Giant GLP Moves Closer to Buyout -- Update